Understanding Mass Spectrometry-based Global Mycobacterial Lipidomics

Area of Science:

• Microbiology
• Biochemistry
• Analytical Chemistry

Background:

• Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a leading infectious cause of death.
• Current TB treatments face challenges including side effects, high costs, and the rise of multidrug resistance (MDR).
• Existing diagnostic methods for TB are often slow and lack reliable biomarkers.

Purpose of the Study:

• To review recent advancements in lipidomics technologies for studying MTB.
• To highlight the potential of lipidomics in identifying novel drug targets and biomarkers for TB.
• To address the challenges and limitations in untargeted or global MTB lipidomics.

Main Methods:

• Review of current lipidomics technologies, including chromatography and detection methods.
• Assessment of mass spectrometry-based tools for untargeted MTB lipidomics.
• Discussion of challenges in analyzing the complex lipid repertoire of MTB.

Main Results:

• Lipidomics provides a comprehensive view of lipid molecules in MTB pathogenesis.
• MTB has a complex lipid metabolism, with lipids comprising 60% of its dry weight.
• Untargeted lipidomics of MTB presents significant analytical challenges.

Conclusions:

• Emerging lipidomics tools offer valuable insights into MTB lipid roles.
• Further technological improvements are needed for robust MTB lipidome analysis.
• Lipidomics holds promise for developing new diagnostic and therapeutic strategies against TB.